The case law distinguishes between so-called “unpredictable arts” (e.g., the biological, chemical, and pharmaceutical arts) ...

Brain diagnostics company Amprion recently closed $6 million from a $15 million total Series B financing round to expand the company's commercial reach ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

They just revealed what they believe are the 10 best stocks for investors to buy right now… See the 10 stocks » *Stock ...

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

The Board also monitors the underlying local value of the Russian ... For now, we expect the obesity market to remain dominated by Novo and Eli Lilly. Looking ahead, we remain positive on Novo’s ...

Zaharieva is a member of the Bulgarian parliament and has served as the ... a potential relief for investors after rival Eli ...

After years of getting persuaded by family members and close friends, Nancy Hanks finally gave in and sent in the application form for the Western Crawford County Bowling Association Hall ...

A celebration of Lakeland Christian Academy's past, present and future was the highlight of a gala Friday, Nov. 1.

Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

dividend-frequency { font-size: 12px; color: #6c757d; } Through an analysis of Eli Lilly, we can infer the following trends: At 86.87, the stock's Price to Earnings ratio significantly exceeds the ...